EQL Pharma AB (publ) (STO:EQL)
Sweden · Delayed Price · Currency is SEK 57.20
+1.20 (2.14%)
At close: Jan 20, 2026
EQL Pharma AB Market Cap
EQL Pharma AB has a market cap or net worth of 1.69 billion as of January 21, 2026. Its market cap has decreased by -28.25% in one year.
Market Cap
1.69B
Enterprise Value
2.06B
Revenue
399.07M
Ranking
n/a
PE Ratio
58.66
Stock Price
57.20
Market Cap Chart
Since December 17, 2013, EQL Pharma AB's market cap has increased from 78.22M to 1.69B, an increase of 2,059.35%. That is a compound annual growth rate of 28.90%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 20, 2026 | 1.69B | -1.04% |
| Dec 30, 2025 | 1.71B | -27.50% |
| Dec 30, 2024 | 2.35B | 142.51% |
| Dec 29, 2023 | 970.72M | 16.78% |
| Dec 30, 2022 | 831.22M | -26.29% |
| Dec 30, 2021 | 1.13B | -2.27% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BioGaia AB | 10.94B |
| Cereno Scientific AB | 1.97B |
| Orexo AB | 1.05B |
| Cinclus Pharma Holding AB | 873.98M |
| Dicot Pharma AB | 592.76M |
| Nanexa AB | 547.43M |
| Enzymatica AB | 463.62M |
| Moberg Pharma AB | 446.51M |